NCT01814501 2025-02-05
Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
Clinical Trials
9 trialsNCT03992456 2024-05-21
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer
Academic and Community Cancer Research United
Phase 2 Active not recruiting
NCT00389870 2022-06-01
Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil
University of Leeds
Phase 3 Completed
NCT03000374 2022-03-17
PIER
Grupo Espanol Multidisciplinario del Cancer Digestivo
Phase 2 Completed
NCT00940316 2019-05-07
Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer
Northwestern University
Phase 2 Completed
NCT01257360 2016-01-13
NEO-RIT
WiSP Wissenschaftlicher Service Pharma GmbH
Phase 2 Unknown
NCT01443377 2015-05-07
NEOREC-1
National Center for Tumor Diseases, Heidelberg
Phase 2 Completed
NCT00814619 2014-04-30
Capecitabine and Radiation Therapy With or Without Panitumumab in Treating Patients With Advanced Rectal Cancer
Swiss Cancer Institute
Phase 2 Completed
NCT00039273 2013-01-08
Monoclonal Antibody Therapy in Treating Patients With Metastatic Colorectal Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Completed